TiGenix NV of Belgium has raised €15.2 million in a rights issue, putting the finishing touches on a merger with Cellerix SA of Spain to create a new, larger company focused on cell-based therapeutics. The issue was fully subscribed. ---Subscribe to MedNous to access this article--- Regenerative Medicine Company News Finance, Grants, Deals
